WAVEFORM
DEAD

Serial Number

88823035

Owner

Waveform Technologies, Inc.

Attorney

Yvonne E. Tingleaf

Filing Date

Mar 5, 2020

Add to watchlist:

No watchlists yet
View on USPTO

WAVEFORM Trademark

Serial Number: 88823035

WAVEFORM is a trademark filed by Waveform Technologies, Inc. on March 5, 2020. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Waveform Technologies, Inc. (3 trademarks)

Suite 100
Wilsonville, OR 97070

Entity Type: 03

Trademark Details

Filing Date

March 5, 2020

Registration Date

Not Registered

Published for Opposition

June 30, 2020

Goods & Services

Digital signal processing apparatus, namely, a programmed microprocessor for incorporation into a medical device for monitoring analytes in interstitial fluids, blood, plasma, or other biological fluids; Digital signal processing apparatus, namely, a programmed microprocessor for incorporation into a medical device for monitoring chronic health conditions; Digital signal processing apparatus, namely, a programmed microprocessor for incorporation into a medical device for monitoring analytes in the human body and automatically or semi-automatically delivering medications to control the analyte concentration to be within a desired range; Digital signal processing apparatus, namely, a programmed microprocessor for incorporation into a medical device for monitoring chronic health conditions and automatically or semi-automatically delivering medications to control or treat the chronic health conditions; Downloadable software in the nature of mobile applications and computer hardware in the nature of microchips for use in the acquisition, processing, analysis, presentation, storage, and transmission of medical and physiological data, namely, data about analytes and chronic health conditions; Downloadable software in the nature of mobile applications and computer hardware in the nature of microchips for use to automatically or semi-automatically deliver medications to control an individual's analyte concentration to be within a desired range or otherwise control or treat an individual's chronic health condition

Medical devices used to monitor analytes in interstitial fluids, blood, plasma, and other biological fluids; Medical devices used to monitor chronic health conditions; Medical sensors inserted into the human body and used to monitor analytes in the human body or monitor a person's chronic health conditions; Medical devices used to monitor analytes in the human body and to manage diabetes by automatically or semi-automatically delivering measured amounts of medications into the bloodstream over time to control the analyte concentration to be within a desired range; Medical devices used to monitor and manage chronic health conditions by automatically or semi-automatically delivering measured amounts of medications into the bloodstream over time to control or treat an individual's chronic health conditions; Analyte and chronic health condition monitor accessories, namely, transmitters, receivers, and medical sensor insertion devices

Providing temporary use of on-line non-downloadable software for use in the acquisition, processing, analysis, presentation, storage, and transmission of medical and physiological data, namely, data about analytes and chronic health conditions; Providing temporary use of on-line non-downloadable software for use in connection with providing information, advice, and coaching in the field of health and wellness; Providing temporary use of on-line non-downloadable software for use in connection with providing medical and physiological data and medical and physiological data monitoring

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Sep 25, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Sep 25, 2023 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 7, 2023 EXRA
SOU EXTENSION 5 GRANTED
Mar 6, 2023 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 3, 2023 AITU
SOU EXTENSION 5 FILED
Feb 17, 2023 EXT5
SOU TEAS EXTENSION RECEIVED
Feb 17, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 19, 2022 EXRA
SOU EXTENSION 4 GRANTED
Aug 17, 2022 EX4G
SOU EXTENSION 4 FILED
Aug 17, 2022 EXT4
SOU TEAS EXTENSION RECEIVED
Aug 17, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 8, 2022 EXRA
SOU EXTENSION 3 GRANTED
Jan 6, 2022 EX3G
SOU EXTENSION 3 FILED
Jan 6, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 6, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 19, 2021 EXRA
SOU EXTENSION 2 GRANTED
Aug 17, 2021 EX2G
SOU EXTENSION 2 FILED
Aug 17, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 17, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 19, 2021 EXRA
SOU EXTENSION 1 GRANTED
Feb 17, 2021 EX1G
SOU EXTENSION 1 FILED
Feb 17, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 17, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 25, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 30, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jun 30, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 10, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 27, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
May 27, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 27, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
May 27, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 27, 2020 CNEA
ASSIGNED TO EXAMINER
May 26, 2020 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 12, 2020 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 11, 2020 NWOS
NEW APPLICATION ENTERED
Mar 9, 2020 NWAP